Health Insurance Agents and Marketers. Health Insurance web Directory: Dental Insurance, Disability Insurance, Discount Plans and quotes, Long Term Care Health Insurance, Medical Savings Accounts - all Health insurance information in one searchable Directory. List of companies offering health insurance to individuals and businesses, information on the kinds of health insurance by product, services or company.
Pharmacy Benefit Management Services
Millennium TPA is a leading provider of pharmacy carve out, pharmacy benefit management services (PBM services) company. We administer drug benefit programs for employers and health insurance carriers across Pennsylvania
Health 1 Insurance
Quality low cost individual, family, and small business health insurance.
A non-insurance healthcare alternative bringing together healthy, caring Christians to share medical costs.
Benefit Resources Group
Offering long term care insurance in the USA. Related articles and legislative updates.
Medical insurance plans for individuals, families and businesses in Indiana and Illinois.
Study says many lung cancer tumors prove harmless
Health care debate has trust, politics themes, too
CHICAGO (AP) — Harmless lung cancer? A provocative study found that nearly 1 in 5 lung tumors detected on CT scans are probably so slow-growing that they would never cause problems.
Uruguay to approve pot dealing, despite risks
WASHINGTON (AP) — For months, the talk was all about computer code. About response times. About glitches and bugs.
U.S. FDA advisory panel backs Takeda bowel disease drug
MONTEVIDEO, Uruguay (AP) — Uruguay is pushing ahead to create a legal marijuana market despite warnings from educators, psychiatrists and pharmacists of dangerous side effects.
An advisory panel of medical experts on Monday voted to recommend that U.S. health regulators approve an experimental drug for ulcerative colitis and Crohn's disease developed by Takeda Pharmaceutical Co. The panel voted by wide margins that the benefits outweigh the risks of the biotech drug, vedolizumab, and advised the Food and Drug Administration to approve it for both ulcerative colitis and Crohn's disease in patients who have not been helped by prior therapies. The FDA typically follows the recommendations of its expert advisory panels, but is not obligated to do so.